Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarshalls Regulatory News (MSLH)

Share Price Information for Marshalls (MSLH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 301.50
Bid: 302.50
Ask: 303.50
Change: -3.50 (-1.15%)
Spread: 1.00 (0.331%)
Open: 303.00
High: 306.50
Low: 301.00
Prev. Close: 305.00
MSLH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Rights Issue

16 Jun 2009 07:00

RNS Number : 9300T
Marshalls PLC
16 June 2009
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA, MALTA, NEW ZEALAND OR ANY OTHER JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL.

Marshalls plc

16 June 2009

Result of Rights Issue

Marshalls plc ("Marshalls" or "the Company") announces that it has received valid acceptances in respect of 50,885,764 New Ordinary Shares, representing approximately 90.4% of the total number of New Ordinary Shares offered to Qualifying Shareholders, pursuant to the Rights Issue announced by the Company on 13 May 2009.

It is expected that the New Ordinary Shares in uncertificated form will be credited to CREST accounts on 16 June 2009 and that definitive share certificates in respect of New Ordinary Shares in certificated form will be dispatched to Shareholders by no later than 23 June 2009. It is expected that the New Ordinary Shares will commence trading fully paid on London Stock Exchange plc's main market for listed securities on 16 June 2009.

As disclosed in Part III of the prospectus sent to shareholders dated 13 May 2009 ("Prospectus"), Citi and Numis will endeavour to procure subscribers for the balance of 5,386,737 New Ordinary Shares not validly taken up under the Rights Issue, on and subject to the terms and conditions agreed with the Company under the Underwriting Agreement. A further announcement as to the number of New Ordinary Shares for which subscribers have been so procured will be made in due course.

Unless otherwise defined in this announcement, capitalised terms shall have the meaning given to them in the Prospectus.

Contacts

 

For further information please contact:

Marshalls plc Tel: +44(0) 1484 438 900

Graham Holden, Chief Executive

Ian Burrell, Finance Director

Brunswick Group LLP  Tel: +44(0) 207 404 5959

Jon Coles

Kate Miller

This announcement does not contain or constitute an offer of, or the solicitation of an offer to buy or subscribe for, securities to any person in Australia, Canada, Japan, South Africa, Malta, New Zealand or the United States or in any jurisdiction to whom or in which such offer or solicitation is unlawful. The securities referred to herein may not be offered or sold in the United States absent registration under the United States Securities Act of 1933, as amended ("Securities Act") or another exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Subject to certain exceptions, the securities referred to herein may not be offered or sold in Australia, Canada, Japan, South Africa, Malta or New Zealand or to, or for the account or benefit of, any national, resident or citizen of Australia, Canada, Japan, South Africa, Malta or New Zealand. The offer and sale of the securities referred to herein has not been and will not be registered under the Securities Act or under the applicable securities laws of Australia, Canada, Japan, South Africa, Malta or New Zealand. There will be no public offer of the securities in the United States. The availability of the Rights Issue to persons not resident in the United Kingdom may be affected by the laws of the relevant jurisdictions. Such persons should inform themselves about and observe any application requirements.

Citigroup Global Markets Limited and Citigroup Global Markets U.K. Equity Limited (each and together, "Citi") and Numis Securities Limited ("Numis") are each regulated and authorised by the Financial Services Authority in the United Kingdom. Citi and Numis are each acting exclusively for the Company and no one else as Joint Bookrunner in connection with the Rights Issue and the Admission of the New Ordinary Shares and will not regard any other person (whether or not a recipient of this announcement) as a client in relation to the Rights Issue and the Admission of the New Ordinary Shares and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Citi or Numis or for providing advice in relation to the Rights Issue, the Admission of the New Ordinary Shares, the contents of this announcement or any matters or arrangements referred to herein or therein.

This announcement is for information only and does not constitute or form part of any offer or invitation to issue, acquire or dispose of any securities or investment advice in any jurisdiction.

This announcement is not a prospectus and investors should not subscribe for or purchase any New Ordinary Shares referred to in this announcement in connection with the Rights Issue except on the basis of the information contained in the Prospectus.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROIEELFFKQBZBBK
Date   Source Headline
12th May 20239:13 amRNSHolding(s) in Company
10th May 20234:48 pmRNSResult of AGM
10th May 202312:53 pmRNSResult of AGM
9th May 20231:06 pmRNSDirector/PDMR Shareholding
9th May 202312:31 pmRNSDirector/PDMR Shareholding
9th May 202310:34 amRNSDirector/PDMR Shareholding
9th May 20237:00 amRNSTrading Statement
4th Apr 20238:57 amRNSAnnual Financial Report
29th Mar 202312:19 pmRNSEBT Share Purchase
20th Mar 20235:25 pmRNSDirector/PDMR Shareholding
17th Mar 20232:00 pmRNSHolding(s) in Company
17th Mar 20231:46 pmRNSDirector/PDMR Shareholding
17th Mar 202311:18 amRNSDirector/PDMR Shareholding
17th Mar 202311:17 amRNSDirector/PDMR Shareholding
17th Mar 20239:08 amRNSDirector/PDMR Shareholding
16th Mar 20232:49 pmRNSDirector/PDMR Shareholding
15th Mar 20232:45 pmRNSDirector/PDMR Shareholding
15th Mar 20237:00 amRNSFinal Results
10th Mar 20239:04 amRNSHolding(s) in Company
20th Feb 202310:42 amRNSHolding(s) in Company
16th Feb 202311:42 amRNSHolding(s) in Company
6th Feb 202311:23 amRNSHolding(s) in Company
3rd Feb 202312:51 pmRNSHolding(s) in Company
1st Feb 20232:21 pmRNSDirector/PDMR Shareholding
27th Jan 20231:32 pmRNSHolding(s) in Company
19th Jan 20237:00 amRNSTrading Statement
13th Jan 20231:55 pmRNSHolding(s) in Company
8th Nov 20222:12 pmRNSDirectorate Change
8th Nov 202212:01 pmRNSHolding(s) in Company
25th Oct 20224:27 pmRNSHolding(s) in Company
7th Oct 20223:36 pmRNSDirector/PDMR Shareholding
7th Oct 20227:00 amRNSTrading Statement
22nd Sep 20227:00 amRNSCapital Markets Day
19th Aug 20223:36 pmRNSDirector/PDMR Shareholding
18th Aug 20227:00 amRNSHalf-year Report
3rd Aug 20224:12 pmRNSHolding(s) in Company
18th Jul 202210:04 amRNSDirector/PDMR Shareholding
14th Jul 202211:51 amRNSDirector/PDMR Shareholding
12th Jul 20227:00 amRNSTrading Statement
11th May 20221:34 pmRNSResult of AGM
11th May 20227:00 amRNSTrading Statement
10th May 20223:14 pmRNSDirector/PDMR Shareholding
10th May 20223:02 pmRNSDirector/PDMR Shareholding
5th May 20229:19 amRNSHolding(s) in Company
3rd May 20224:20 pmRNSHolding(s) in Company
3rd May 20223:09 pmRNSDirector/PDMR Shareholding
3rd May 20223:08 pmRNSDirector/PDMR Shareholding
3rd May 20223:07 pmRNSDirector/PDMR Shareholding
3rd May 20223:06 pmRNSDirector/PDMR Shareholding
3rd May 20223:03 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.